Bipolar Disorder Clinical Trial
Official title:
A Proof of Concept Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
This study is being done to see if icariin will help with depression in patients with bipolar disorder and alcohol or cocaine use disorders. The pills used in this study contain 20% icariin.
Ten adults with current bipolar disorder (BPD) and current cocaine or alcohol use disorders,
based on a structured clinical interview (SCID), and a baseline Hamilton Rating Scale for
Depression (HAMD) score of ≥ 15, will be recruited through a patient database of a recently
completed study of bipolar disorder patients with cocaine dependence. Informed consent will
be obtained. The clinician version of the structured Clinical Interview for DSM-IV (SCID) is
a brief structured interview for major Axis I disorders in DSM-IV including major depressive
disorder, dysthymic disorder, bipolar disorders, psychotic disorders, anxiety disorders,
eating disorders, and alcohol and substance abuse/dependence. This will be given at baseline
to confirm bipolar disorder diagnosis. Blood draws and a physical examination by a physician
will be performed at baseline to general physical health. Participants will return to
receive icariin (100 mg/day)once their general health and diagnosis are confirmed.
Participants will be assessed at baseline and weekly with the HAMD and a urine drug screen,
for 8 consecutive weeks after initiating intervention (icariin). A dose titration from 100
mg/day to 200 mg/day will be allowed at week 3 for participants with less than a 30%
reduction in HAMD and/or still using cocaine or alcohol or have a positive urine drug
screen. An additional dose titration to 300 mg/day will be allowed at week 6 for
participants with less than a 50% reduction in HAMD scores and/or still using cocaine or
alcohol or have a positive urine drug screen.
Pill counts will be conducted, and a list of current medications and doses will be obtained
at each visit. Participants will be compensated and receive bus passes at each appointment.
Participants will be evaluated by both the research assistant (RA) and principal
investigator (PI) at each follow-up appointment.
The HAM-D will be the primary outcome measure. Other cognitive assessments will be performed
at these same visits as well.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |